Improved generation of induced cardiomyocytes using a polycistronic construct expressing optimal ratio of Gata4, Mef2c And Tbx5

Journal of Visualized Experiments

Volumn 2015, Issue 105, 2015, Pages

  Wang, Li ^a   Liu, Ziqing ^a   Yin, Chaoying ^a   Zhou, Yang ^a   Liu, Jiandong ^a   Qian, Li ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac fibroblast; Cardiomyocytes; Developmental biology; Direct reprogramming; Gata4; ICM; Issue 105; Mef2c; MGT polycistronic construct; Tbx5

Indexed keywords

EID: 84949464639     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/53426     Document Type: Article

References (31)

1. Mozaffarian, D., et al. Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association. Circulation., (2014).
2. Whelan, R. S., Kaplinskiy, V., & Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol., 72, 19-44, (2010).
3. Senyo, S.E., et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 493, 433-436, (2013).
4. Soonpaa, M. H., & Field, L. J. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol. 272, H220-H226 (1997).
5. Hosoda, T., et al. Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A. 106, 17169-17174, (2009).
6. Choi, W. Y., & Poss, K.D., Cardiac regeneration. Curr Top Dev Biol. 100, 319-344, (2012).
7. Souders, C. A., Bowers, S. L., & Baudino, T. A. Cardiac fibroblast: the renaissance cell. Circ Res. 105, 1164-1176, (2009).
8. Ieda, M., et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell. 16, 233-244, (2009).
9. Moore-Morris, T., et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Invest. 124, 2921-2934, (2014).
10. Addis, R.C., et al. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol. 60, 97-106, (2013).
11. Chen, J.X., et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res. 111, 50-55, (2012).
12. Christoforou, N., et al. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One. 8, e63577, (2013).
13. Fu, J.D., et al. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Reports. 1, 235-247, (2013).
14. Hirai, H., Katoku-Kikyo, N., Keirstead, S. A., & Kikyo, N. Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain. Cardiovasc Res. 100, 105-113, (2013).
15. Ieda, M., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 142, 375-386, (2010).
16. Inagawa, K., et al. Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5. Circ Res. 111, 1147-1156, (2012).
17. Islas, J.F., et al. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci U.S.A. 109, 13016-13021, (2012).
18. Jayawardena, T.M., et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 110, 1465-1473, (2012).
19. Muraoka, N., et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. Embo J. 33, 1565-1581, (2014).
20. Nam, Y.J., et al. Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development. 141, 4267-4278, (2014).
21. Nam, Y.J., et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A. 110, 5588-5593, (2013).
22. Protze, S., et al. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol. 53, 323-332, (2012).
23. Qian, L., Berry, E.C., Fu, J.D., Ieda, M., & Srivastava, D., Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro. Nat Protoc. 8, 1204-1215, (2013).
24. Wang, H., et al. Small Molecules Enable Cardiac Reprogramming of Mouse Fibroblasts with a Single Factor, Oct4. Cell Rep., (2014).
25. Wang, L., et al. Stoichiometry of Gata4, Mef2c, and Tbx5 Influences the Efficiency and Quality of Induced Cardiac Myocyte Reprogramming. Circ Res., (2014).
26. Song, K., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 485, 599-604, (2012).
27. Qian, L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 485, 593-598, (2012).
28. Mathison, M., et al. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 1, e005652, (2012).
29. Srivastava, D., Ieda, M., Fu, J., & Qian, L. Cardiac repair with thymosin beta4 and cardiac reprogramming factors. Ann N Y Acad Sci. 1270, 66-72, (2012).
30. Muraoka, N., & Ieda, M. Stoichiometry of transcription factors is critical for cardiac reprogramming. Circ Res. 116, 216-218, (2015).
31. Srivastava, D., & Ieda, M. Critical factors for cardiac reprogramming. Circ Res. 111, 5-8, (2012).